Goldman Sachs · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Goldman Sachs Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 15.4M | $4.1B | — |
| 2024Q2 | 2.3M | $975M | -76.1% |
| 2024Q3 | 1.6M | $643M | -34.1% |
| 2024Q4 | 1.9M | $589M | -8.3% |
| 2025Q1 | 4.2M | $1.7B | +193.0% |
| 2025Q2 | 4.5M | $1.7B | +0.2% |
| 2025Q3 | 1.9M | $592M | -65.8% |
| 2025Q4 | 2.9M | $817M | +37.9% |
| 2026Q1 | 7.6M | $1.9B | +135.7% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F